Search research articles
Contact Us
Filters
Showing results (81-90 of 183) with videos related to
Page
of 19
Sort By:
Cancer Treatment and Research
|
January 1, 1996
Detection of minimal residual disease in all: biology, methods, and applications
W M Roberts, Z Estrov, G R Kitchingman, et al.
Leukemia & Lymphoma
|
January 1, 1996
The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification by antigen-receptor gene sequences
W M Roberts, Z Estrov, G R Kitchingman, et al.
Methods (San Diego, Calif.)
|
January 1, 1997
Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes
K McClain, Z Estrov, U Raju, et al.
The American Journal of Gastroenterology
|
October 1, 1986
Secretory piece and IgA deficiency in a patient with Waldenstrom's macroglobulinemia
E Nussinson, M Lahav, A Berebi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1991
Phase I study of recombinant human interleukin-3 in patients with bone marrow failure
R Kurzrock, M Talpaz, Z Estrov, et al.
Human Pathology
|
May 1, 1997
Physiology and pathophysiology of dendritic cells
V Wright-Browne, K L McClain, M Talpaz, et al.
The Journal of Clinical Investigation
|
October 1, 1994
Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies
M Talpaz, Z Estrov, H Kantarjian, et al.
Experimental Hematology
|
October 1, 1985
Growth inhibitory effect of gene-cloned interferons on human myeloblast colonies
M H Freedman, E Fish, Z Estrov, et al.
Leukemia
|
May 1, 1987
Effect of deferoxamine on DNA synthesis, DNA repair, cell proliferation, and differentiation of HL-60 cells
C Kaplinsky, Z Estrov, M H Freedman, et al.
Leukemia Research
|
June 1, 1997
Suppressed formation of bone marrow adherent layers derived from acute myeloid leukemia patients after in vitro exposure to interleukin-4
M Wetzler, R Kurzrock, Z Estrov, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 183) with videos related to
Sort By:
Page
of 19
Cancer Treatment and Research
|
January 1, 1996
Detection of minimal residual disease in all: biology, methods, and applications
W M Roberts, Z Estrov, G R Kitchingman, et al.
Leukemia & Lymphoma
|
January 1, 1996
The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification by antigen-receptor gene sequences
W M Roberts, Z Estrov, G R Kitchingman, et al.
Methods (San Diego, Calif.)
|
January 1, 1997
Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes
K McClain, Z Estrov, U Raju, et al.
The American Journal of Gastroenterology
|
October 1, 1986
Secretory piece and IgA deficiency in a patient with Waldenstrom's macroglobulinemia
E Nussinson, M Lahav, A Berebi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1991
Phase I study of recombinant human interleukin-3 in patients with bone marrow failure
R Kurzrock, M Talpaz, Z Estrov, et al.
Human Pathology
|
May 1, 1997
Physiology and pathophysiology of dendritic cells
V Wright-Browne, K L McClain, M Talpaz, et al.
The Journal of Clinical Investigation
|
October 1, 1994
Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies
M Talpaz, Z Estrov, H Kantarjian, et al.
Experimental Hematology
|
October 1, 1985
Growth inhibitory effect of gene-cloned interferons on human myeloblast colonies
M H Freedman, E Fish, Z Estrov, et al.
Leukemia
|
May 1, 1987
Effect of deferoxamine on DNA synthesis, DNA repair, cell proliferation, and differentiation of HL-60 cells
C Kaplinsky, Z Estrov, M H Freedman, et al.
Leukemia Research
|
June 1, 1997
Suppressed formation of bone marrow adherent layers derived from acute myeloid leukemia patients after in vitro exposure to interleukin-4
M Wetzler, R Kurzrock, Z Estrov, et al.
Page
of 19